mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.009 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.009 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.009 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.009 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.009 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.15 |
0.01 |